Real-world outcomes of pembrolizumab plus carboplatin plus paclitaxel or nab-paclitaxel in non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Tabah, Ashley
Huggar, David
Kish, Jonathan
Bapat, Bela
Liassou, Djibril
Gajra, Ajeet
Miller, Talia
Copher, Ronda
Patel, Manali, I
机构：
[1] Bristol Myers Squibb, Summit, NJ USA
[2] Cardinal Hlth, Dublin, OH USA
[3] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21717
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Bevacizumab Plus Carboplatin Plus Nab-paclitaxel for Non-squamous Non-small Cell Lung Cancer in a Real-world Setting
    Tamiya, Akihiro
    Tamiya, Motohiro
    Inagaki, Yuji
    Taniguchi, Yoshihiko
    Nakao, Keiko
    Matsuda, Yoshinobu
    Kawamura, Takahisa
    Kunimasa, Kei
    Inoue, Takako
    Nishino, Kazumi
    Okishio, Kyoichi
    ANTICANCER RESEARCH, 2023, 43 (03) : 1325 - 1330
  • [2] nab-Paclitaxel plus Carboplatin in Advanced Non-Small Cell Lung Cancer NSCLC: Dose Modification Analysis
    Postmus, Pieter E.
    O'Brien, Mary E. R.
    Socinski, Mark A.
    Li, Li
    Ong, Teng Jin
    Gridelli, Cesare
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S658 - S658
  • [3] Efficacy and safety of weekly nab-paclitaxel plus carboplatin advanced non-small cell lung cancer
    Satouchi, Miyako
    Okamoto, Isamu
    Sakai, Hiroshi
    Yamamoto, Nobuyuki
    Ichinose, Yukito
    Ohmatsu, Hironobu
    Nogami, Naoyuki
    Takeda, Koji
    Mitsudomi, Tetsuya
    Kasahara, Kazuo
    Negoro, Shunichi
    LUNG CANCER, 2013, 81 (01) : 97 - 101
  • [4] Interim Results From the Phase I Study of Nivolumab plus nab-Paclitaxel plus Carboplatin in Non-Small Cell Lung Cancer (NSCLC)
    Goldman, Jonathan W.
    George, Ben
    Gutierrez, Martin
    Ko, Amy
    O'Dwyer, Peter
    Otterson, Gregory
    Soliman, Hatem
    Trunova, Nataliya
    Waterhouse, David
    Kelly, Karen
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1309 - S1309
  • [5] nab-Paclitaxel plus Carboplatin in Advanced Non-Small Cell Lung Cancer: Outcomes in Elderly Patients With Squamous Histology
    Gridelle, Cesare
    Chen, Tianlei
    Ko, Amy
    Ong, Teng Jin
    O'Brien, Mary
    Socinski, Mark
    Postmus, Pieter
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S213 - S213
  • [6] nab-paclitaxel plus carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND. sqm study
    Spigel, D. R.
    Jotte, R. M.
    Ponce Aix, S.
    Gressot, L.
    Morgensztern, D.
    McCleod, M.
    Socinski, M. A.
    Daniel, D.
    Juan-Vidal, O.
    Kim, E. S.
    West, H. J.
    Chen, T.
    Bhore, R.
    Ong, T. J.
    Gridelli, C.
    Thomas, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] Carboplatin/nab-Paclitaxel and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 1 Results
    Gentzler, R. D.
    Mohindra, N. A.
    Hanna, N.
    Chae, Y. K.
    Jalal, S. I.
    Hall, R.
    Villaflor, V. M.
    Reckamp, K. L.
    Koczywas, M.
    Sullivan, D.
    Wood, L.
    Patel, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 236 - 236
  • [8] EFFICACY OF CARBOPLATIN plus WEEKLY NAB-PACLITAXEL FOR ELDERLY ADVANCED/RECURRENT NON-SMALL CELL LUNG CANCER (E-NSCLC)
    Shibata, Kazuhiko
    Shibata, Yoshihiro
    Takase, Misae
    Takahashi, Miyuki
    ANNALS OF ONCOLOGY, 2014, 25
  • [9] Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion
    Tamiya, Motohiro
    Tamiya, Akihiro
    Suzuki, Hidekazu
    Taniguchi, Yoshihiko
    Katayama, Kanako
    Minomo, Shojiro
    Nakao, Keiko
    Takeuchi, Naoko
    Matsuda, Yoshinobu
    Naito, Yujiro
    Shiroyama, Takayuki
    Okamoto, Norio
    Okishio, Kyoichi
    Kumagai, Toru
    Atagi, Shinji
    Imamura, Fumio
    Hirashima, Tomonori
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (04) : 1106 - 1112
  • [10] Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease
    Igawa, Satoshi
    Nishinarita, Noriko
    Takakura, Akira
    Ozawa, Takahiro
    Harada, Shinya
    Kusuhara, Seiichiro
    Niwa, Hideyuki
    Hosotani, Shinji
    Sone, Hideyuki
    Nakahara, Yoshiro
    Fukui, Tomoya
    Mitsufuji, Hisashi
    Yokoba, Masanori
    Kubota, Masaru
    Katagiri, Masato
    Sasaki, Jiichiro
    Naoki, Katsuhiko
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 7013 - 7019
12345